Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Franck E. Nicolini, H. Jean Khoury, Luke Akard, Delphine Rea, Hagop Kantarjian, Michele Baccarani, Janis Leonoudakis, Adam Craig, Annie Claude Benichou, Jorge Cortes

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)e78-e79
Issue number7
StatePublished - Jul 2013
Externally publishedYes


  • Advanced chronic myeloid leukemia
  • Dasatinib
  • Homoharringtonine
  • Imatinib
  • Nilotinib
  • Omacetaxine
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Hematology

Cite this